SPECTRUM PHARMACEUTICALS INC — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$10.1M

Net Income/Loss (FY2022)

-$75.4M

Total Assets (FY2022)

$103.3M

Total Equity (FY2022)

$27.9M

Cash Flows from Operating Activities (FY2022)

-$97.0M

Source: SPECTRUM PHARMACEUTICALS INC 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.